Oruka Therapeutics, Inc. ORKA Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s total liabilities & equity?
- Oruka Therapeutics, Inc. (ORKA) reported total liabilities & equity of $504.48M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s total liabilities & equity changed year-over-year?
- Oruka Therapeutics, Inc.'s total liabilities & equity increased by 33.8% year-over-year, from $377.11M to $504.48M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s total liabilities & equity has grown at a 57.5% compound annual growth rate (CAGR), from $50.43M to $488.62M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.